Device Shoulder - Implants - Speedbridge - Composite Anchors

Shoulder Implants Speedbridge Composite Anchors

Payments companies reported to CMS as associated with Shoulder Implants Speedbridge Composite Anchors. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1,978associated payments (2023-2025)
20clinicians with associated payments
1company reporting

By year

2023 $1,869
2024 $109

Payments reported as associated with Shoulder Implants Speedbridge Composite Anchors, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Surgery $1,136
Sports Medicine (Orthopaedic Surgery) $741
Acute Care (Nurse Practitioner) $101

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Shoulder Implants Speedbridge Composite Anchors

These are the largest totals companies reported as associated with Shoulder Implants Speedbridge Composite Anchors. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Joseph Lynch Boise, ID Orthopaedic Surgery $125.68
Stephen O Connell Rancho Mirage, CA Orthopaedic Surgery $119.74
David Savin Palm Springs, CA Orthopaedic Surgery $119.74
Asghar Husain Rancho Cucamonga, CA Sports Medicine (Orthopaedic Surgery) $119.74
Shahram Solhpour Fullerton, CA Orthopaedic Surgery $119.74
Rebecca Griffith Highland, CA Orthopaedic Surgery $119.74
Wesley Phipatanakul Loma Linda, CA Sports Medicine (Orthopaedic Surgery) $119.74
Andrew Hsiao Whittier, CA Sports Medicine (Orthopaedic Surgery) $119.74
Patrick St Pierre Rancho Mirage, CA Orthopaedic Surgery $119.74
Bret Powers Corona, CA Sports Medicine (Orthopaedic Surgery) $119.73

Prescribed Shoulder Implants Speedbridge Composite Anchors?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.